About Us

At Ampulis, we’re not just creating drug delivery solutions; we’re accelerating the availability of life-saving and life-changing medications.

Our Mission

Develop safe, user-focused, and reliable solutions to speed up patient access to life-saving treatments.

Our Team: Deep Experience Delivering Results

Our world-class team of experts is built on decades of experience in drug delivery design, operations, human factors, and manufacturing. We move fast, and our track record speaks for itself.

Eric Sugalski, MBA

Chief Executive Officer

Eric Sugalski has over 2 decades of experience in design, regulatory, and commercial aspects in medical devices. At Ampulis, Eric leads corporate strategy and pharma partnerships while keeping a hand in operational activities.

Michael Baratta, MBA

Operations Lead

Michael Baratta has over 30 years experience leading combination product teams in engineering, supply chain, and operations. At Ampulis, Michael leads product management and works with supply chain and manufacturing partners to execute with precision and control.

Lynn Brown, CPA

Director of Finance & Administration

Lynn Brown has over 25 years experience leading financial operations and administrative functions within various organizations. At Ampulis, Lynn leads financial and administrative operations collaborating closely with leadership on strategic decisions.

Joseph Jackson

Engineering Lead

Joseph Jackson has over 2 decades of hands-on experience developing drug delivery and other medical devices. At Ampulis, Joe leads the detailed design process ensuring that functional, manufacturing, and cost targets are being achieved.

Aidan Hyde

Human Factors Lead

Aidan Hyde has over 25 years experience optimizing medical devices for usability. At Ampulis, Aidan leads the human factors process gaining insights from customers that drive design decisions and confirming that user related risks have been mitigated.

James Curtis, PharmD

Pharmacy Lead

James Curtis has over 20 years experience as a pharmacist and pharmacy manager at major healthcare institutions. At Ampulis, James advises on critical pharmacy operational issues that drive design and labeling decisions.

Craig Steiner, MD

Emergency Med Lead

Craig Steiner has over 30 years experience as an anesthesiologist, heavily involved in emergency medicine. At Ampulis, Craig advises on clinical and operational issues that drive design decisions to optimize clinical safety and effectiveness.

James Scull, PhD

Drug Stability Lead

James Scull has over 30 years of experience at the intersection of drug-device interactions. At Ampulis, James manages extractables & leachables testing, particulate analysis, and other analytical tests to address regulatory and commercial needs.

Our Approach: Speed, Precision, and Collaboration

At Ampulis, we don’t just offer drug delivery devices; we provide tailored solutions that evolve alongside your product. Our process is fast, flexible, and designed for seamless collaboration to meet your regulatory, clinical, and commercial needs.

PHASE 1

ASSESSMENT
Fast Feasibility Checks

In just 4-6 weeks, we assess your drug’s unique needs to determine if the AFS platform is the right fit. This phase includes feasibility assessments, costing, timeline estimates, and an execution plan, so you can make a go/no-go decision quickly.

PHASE 2

CUSTOM DEVELOPMENT
Speed Meets Precision

Over 6-8 months, we customize the AFS platform to your drug’s specifications. This includes design updates, prototype assembly, and comprehensive testing. By the end of this phase, your solution will be uniquely tailored for branding, labeling, and regulatory needs.

PHASE 3

DESIGN VERIFICATION
Ready for Regulatory Filing

Within 4-6 months, we’ll complete mechanical testing, analytical testing, and human factors evaluations. The result? A comprehensive report package, ready for regulatory filings and your next step.

PHASE 4

CLINICAL BUILDS
Fast, Reliable Units for Clinical Testing

In 2-3 months, we produce cGMP-built units to support your clinical testing needs, ensuring full traceability with Device History Records (DHRs).

PHASE 5

SCALE-UP
From Prototype to Production

Once you’re ready to scale, we work with best-in-class contract manufacturers to set up the supply chain and automation needed for mass production. Expect this phase to take 8-12 months, depending on the scale.

Explore Manufacturing Partnerships

When it’s time to scale up, we’ve already secured partnerships with top-tier contract manufacturing organizations (CMOs) to ensure your production volumes are met under strict quality controls.

Get to know Ampulis and AFS

We’d love to share more about our platform and how we can help accelerate your drug delivery process. Sign up for our email series to stay in the loop!

Ready to take the next step?

Schedule a demo call for an in-depth product overview.